

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.44272540 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.44272540 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.14539770 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.97119592 |
| 5 | negative regulation of cell killing (GO:0031342) | 4.97119592 |
| 6 | detection of other organism (GO:0098543) | 4.63077936 |
| 7 | detection of bacterium (GO:0016045) | 4.58969398 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.35839744 |
| 9 | negative regulation of phagocytosis (GO:0050765) | 4.15399741 |
| 10 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.98042716 |
| 11 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.98042716 |
| 12 | B cell mediated immunity (GO:0019724) | 3.88373436 |
| 13 | regulation of mast cell degranulation (GO:0043304) | 3.87883194 |
| 14 | cellular extravasation (GO:0045123) | 3.87126681 |
| 15 | neutrophil activation (GO:0042119) | 3.86047385 |
| 16 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.84493137 |
| 17 | leukocyte aggregation (GO:0070486) | 3.81031613 |
| 18 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.78527165 |
| 19 | detection of external biotic stimulus (GO:0098581) | 3.76742104 |
| 20 | regulation of gamma-delta T cell activation (GO:0046643) | 3.71750274 |
| 21 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.67818978 |
| 22 | granulocyte activation (GO:0036230) | 3.65221841 |
| 23 | myeloid cell activation involved in immune response (GO:0002275) | 3.59706455 |
| 24 | response to host immune response (GO:0052572) | 3.57812845 |
| 25 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.57812845 |
| 26 | pentose-phosphate shunt (GO:0006098) | 3.54337081 |
| 27 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.52923582 |
| 28 | Golgi transport vesicle coating (GO:0048200) | 3.49643015 |
| 29 | COPI coating of Golgi vesicle (GO:0048205) | 3.49643015 |
| 30 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.48947354 |
| 31 | regulation of leukocyte degranulation (GO:0043300) | 3.48406982 |
| 32 | response to muramyl dipeptide (GO:0032495) | 3.45847248 |
| 33 | positive thymic T cell selection (GO:0045059) | 3.43483988 |
| 34 | positive regulation of mast cell activation (GO:0033005) | 3.41482906 |
| 35 | microglial cell activation (GO:0001774) | 3.41438386 |
| 36 | detection of biotic stimulus (GO:0009595) | 3.38965238 |
| 37 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.37533667 |
| 38 | positive regulation of B cell differentiation (GO:0045579) | 3.35071630 |
| 39 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.34313287 |
| 40 | type I interferon signaling pathway (GO:0060337) | 3.27762956 |
| 41 | cellular response to type I interferon (GO:0071357) | 3.27762956 |
| 42 | DNA deamination (GO:0045006) | 3.27554572 |
| 43 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.27378703 |
| 44 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.26523422 |
| 45 | alpha-linolenic acid metabolic process (GO:0036109) | 3.24243306 |
| 46 | response to type I interferon (GO:0034340) | 3.23847845 |
| 47 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.23841557 |
| 48 | response to host (GO:0075136) | 3.23841557 |
| 49 | response to host defenses (GO:0052200) | 3.23841557 |
| 50 | respiratory burst (GO:0045730) | 3.23759452 |
| 51 | valine metabolic process (GO:0006573) | 3.23644354 |
| 52 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.22969036 |
| 53 | detection of molecule of bacterial origin (GO:0032490) | 3.22548513 |
| 54 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.22504286 |
| 55 | response to protozoan (GO:0001562) | 3.21419618 |
| 56 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.20092945 |
| 57 | regulation of mast cell activation (GO:0033003) | 3.19874880 |
| 58 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.19516820 |
| 59 | protein retention in ER lumen (GO:0006621) | 3.18402619 |
| 60 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.18118057 |
| 61 | positive regulation of mast cell degranulation (GO:0043306) | 3.13745389 |
| 62 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.13745389 |
| 63 | NADPH regeneration (GO:0006740) | 3.13473155 |
| 64 | macrophage activation (GO:0042116) | 3.13429247 |
| 65 | negative regulation of granulocyte differentiation (GO:0030853) | 3.12079364 |
| 66 | ribosomal small subunit assembly (GO:0000028) | 3.11675031 |
| 67 | disruption of cells of other organism (GO:0044364) | 3.11006458 |
| 68 | killing of cells of other organism (GO:0031640) | 3.11006458 |
| 69 | leukocyte degranulation (GO:0043299) | 3.09945112 |
| 70 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.06129593 |
| 71 | neutrophil mediated immunity (GO:0002446) | 3.03756436 |
| 72 | positive regulation of antigen processing and presentation (GO:0002579) | 3.03384042 |
| 73 | low-density lipoprotein particle remodeling (GO:0034374) | 3.02962318 |
| 74 | positive regulation by symbiont of host defense response (GO:0052509) | 3.01355130 |
| 75 | modulation by symbiont of host defense response (GO:0052031) | 3.01355130 |
| 76 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.01355130 |
| 77 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.01355130 |
| 78 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.01355130 |
| 79 | modulation by symbiont of host immune response (GO:0052553) | 3.01355130 |
| 80 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.00075826 |
| 81 | L-phenylalanine metabolic process (GO:0006558) | 3.00075826 |
| 82 | mannose metabolic process (GO:0006013) | 2.99220622 |
| 83 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.97582331 |
| 84 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.96749363 |
| 85 | NIK/NF-kappaB signaling (GO:0038061) | 2.92905564 |
| 86 | neutrophil activation involved in immune response (GO:0002283) | 2.92757665 |
| 87 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.92363213 |
| 88 | immunoglobulin mediated immune response (GO:0016064) | 2.91114890 |
| 89 | negative thymic T cell selection (GO:0045060) | 2.91060063 |
| 90 | negative regulation of innate immune response (GO:0045824) | 2.90869425 |
| 91 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.87742463 |
| 92 | protein carboxylation (GO:0018214) | 2.87742463 |
| 93 | regulation of regulated secretory pathway (GO:1903305) | 2.87178338 |
| 94 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.87147678 |
| 95 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.85052540 |
| 96 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.84764532 |
| 97 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.83643867 |
| 98 | regulation of B cell differentiation (GO:0045577) | 2.83625529 |
| 99 | peptide catabolic process (GO:0043171) | 2.83617468 |
| 100 | negative regulation of interleukin-12 production (GO:0032695) | 2.83427955 |
| 101 | regulation of superoxide anion generation (GO:0032928) | 2.81703845 |
| 102 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.81344962 |
| 103 | sulfur amino acid catabolic process (GO:0000098) | 2.79351076 |
| 104 | high-density lipoprotein particle remodeling (GO:0034375) | 2.79306850 |
| 105 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.79119440 |
| 106 | negative T cell selection (GO:0043383) | 2.75497745 |
| 107 | polyketide metabolic process (GO:0030638) | 2.75483269 |
| 108 | doxorubicin metabolic process (GO:0044598) | 2.75483269 |
| 109 | daunorubicin metabolic process (GO:0044597) | 2.75483269 |
| 110 | macrophage activation involved in immune response (GO:0002281) | 2.75303416 |
| 111 | negative regulation of T cell mediated immunity (GO:0002710) | 2.75289351 |
| 112 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.75016743 |
| 113 | B cell receptor signaling pathway (GO:0050853) | 2.74409021 |
| 114 | L-phenylalanine catabolic process (GO:0006559) | 2.74123460 |
| 115 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.74123460 |
| 116 | T cell migration (GO:0072678) | 2.73859157 |
| 117 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.73408526 |
| 118 | positive regulation of interferon-alpha production (GO:0032727) | 2.72698876 |
| 119 | primary alcohol catabolic process (GO:0034310) | 2.72551241 |
| 120 | response to interleukin-15 (GO:0070672) | 2.72271235 |
| 121 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.70671686 |
| 122 | regulation of tolerance induction (GO:0002643) | 2.70619227 |
| 123 | response to peptidoglycan (GO:0032494) | 2.69627554 |
| 124 | defense response to fungus (GO:0050832) | 2.69475369 |
| 125 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.69138617 |
| 126 | T cell selection (GO:0045058) | 2.69055996 |
| 127 | negative regulation of interleukin-6 production (GO:0032715) | 2.68761419 |
| 128 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.68609938 |
| 129 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.66863240 |
| 130 | macrophage differentiation (GO:0030225) | 2.66845196 |
| 131 | ethanol oxidation (GO:0006069) | 2.66805509 |
| 132 | negative regulation of sterol transport (GO:0032372) | 2.65632949 |
| 133 | negative regulation of cholesterol transport (GO:0032375) | 2.65632949 |
| 134 | glucose catabolic process (GO:0006007) | 2.65266305 |
| 135 | response to fungus (GO:0009620) | 2.64730334 |
| 136 | reverse cholesterol transport (GO:0043691) | 2.61465921 |
| 137 | complement activation, alternative pathway (GO:0006957) | 2.61310463 |
| 138 | sterol catabolic process (GO:0016127) | 2.61149415 |
| 139 | cholesterol catabolic process (GO:0006707) | 2.61149415 |
| 140 | phospholipid efflux (GO:0033700) | 2.60982504 |
| 141 | response to interferon-beta (GO:0035456) | 2.59102273 |
| 142 | protein-lipid complex remodeling (GO:0034368) | 2.57835282 |
| 143 | macromolecular complex remodeling (GO:0034367) | 2.57835282 |
| 144 | plasma lipoprotein particle remodeling (GO:0034369) | 2.57835282 |
| 145 | regulation of lipoprotein particle clearance (GO:0010984) | 2.57308300 |
| 146 | aromatic amino acid family catabolic process (GO:0009074) | 2.55834373 |
| 147 | regulation of antigen processing and presentation (GO:0002577) | 2.54115444 |
| 148 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.51565335 |
| 149 | necroptotic process (GO:0070266) | 2.50780434 |
| 150 | regulation of interferon-alpha production (GO:0032647) | 2.50536613 |
| 151 | cellular response to zinc ion (GO:0071294) | 2.50110397 |
| 152 | bile acid biosynthetic process (GO:0006699) | 2.49999233 |
| 153 | tryptophan catabolic process (GO:0006569) | 2.48952449 |
| 154 | indole-containing compound catabolic process (GO:0042436) | 2.48952449 |
| 155 | indolalkylamine catabolic process (GO:0046218) | 2.48952449 |
| 156 | pinocytosis (GO:0006907) | 2.47268455 |
| 157 | pentose metabolic process (GO:0019321) | 2.46563909 |
| 158 | regulation of phagocytosis (GO:0050764) | 2.46177435 |
| 159 | complement activation, classical pathway (GO:0006958) | 2.44921238 |
| 160 | tryptophan metabolic process (GO:0006568) | 2.44512104 |
| 161 | defense response to protozoan (GO:0042832) | 2.43932819 |
| 162 | mature B cell differentiation involved in immune response (GO:0002313) | 2.42879631 |
| 163 | signal peptide processing (GO:0006465) | 2.42163866 |
| 164 | kynurenine metabolic process (GO:0070189) | 2.41197792 |
| 165 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.39582262 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.89687897 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.80269771 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.18139178 |
| 4 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.95416909 |
| 5 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.82477861 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.72661263 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 2.65796025 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.64818873 |
| 9 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.64613157 |
| 10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.59530113 |
| 11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.55321118 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.53410167 |
| 13 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.47755784 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.41702917 |
| 15 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.41294726 |
| 16 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.40723170 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.40195039 |
| 18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.28157824 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.24068502 |
| 20 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.23525106 |
| 21 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.20948866 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.16982463 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 2.15603135 |
| 24 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.15165900 |
| 25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.14235390 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.04818734 |
| 27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.04498275 |
| 28 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.96084279 |
| 29 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.92945788 |
| 30 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.92099278 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.89127229 |
| 32 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87970319 |
| 33 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.85101516 |
| 34 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.82341011 |
| 35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.80919226 |
| 36 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.80615820 |
| 37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.80472894 |
| 38 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.76216893 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76035814 |
| 40 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75195782 |
| 41 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.75083908 |
| 42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.66918113 |
| 43 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.66277262 |
| 44 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.66256287 |
| 45 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65766460 |
| 46 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.65592741 |
| 47 | MAF_26560356_Chip-Seq_TH1_Human | 1.63682210 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.61666818 |
| 49 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.57326091 |
| 50 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.55983704 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.55464474 |
| 52 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.55292565 |
| 53 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.52914079 |
| 54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52681147 |
| 55 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.52010427 |
| 56 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.48795564 |
| 57 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.48272893 |
| 58 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.44065811 |
| 59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43492012 |
| 60 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40115840 |
| 61 | UTX_26944678_Chip-Seq_JUKART_Human | 1.39244799 |
| 62 | MYB_26560356_Chip-Seq_TH2_Human | 1.39159305 |
| 63 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.38775722 |
| 64 | MYB_26560356_Chip-Seq_TH1_Human | 1.33278225 |
| 65 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.31018825 |
| 66 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28243812 |
| 67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26309315 |
| 68 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.26104476 |
| 69 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.25551823 |
| 70 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.25213948 |
| 71 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.23352717 |
| 72 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.23062857 |
| 73 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.21295640 |
| 74 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.21235267 |
| 75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20267174 |
| 76 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.20213355 |
| 77 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.17974298 |
| 78 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15881719 |
| 79 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.12261107 |
| 80 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.10627446 |
| 81 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10120003 |
| 82 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.09988999 |
| 83 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.09755691 |
| 84 | MAF_26560356_Chip-Seq_TH2_Human | 1.09455716 |
| 85 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.09445195 |
| 86 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.09399377 |
| 87 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08290132 |
| 88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08260491 |
| 89 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07350425 |
| 90 | P68_20966046_ChIP-Seq_HELA_Human | 1.06828605 |
| 91 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06725423 |
| 92 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05999722 |
| 93 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.05997538 |
| 94 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.05448418 |
| 95 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05265528 |
| 96 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.05258773 |
| 97 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04621180 |
| 98 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04298632 |
| 99 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.04144825 |
| 100 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.03013020 |
| 101 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01295008 |
| 102 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.99872050 |
| 103 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98591021 |
| 104 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.97594534 |
| 105 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.97059908 |
| 106 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95669273 |
| 107 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.95249821 |
| 108 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.95151998 |
| 109 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.94710902 |
| 110 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.94551112 |
| 111 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.94075661 |
| 112 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.93933594 |
| 113 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.92705084 |
| 114 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.92307948 |
| 115 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92297056 |
| 116 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91941759 |
| 117 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.91842318 |
| 118 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.91752415 |
| 119 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.91259451 |
| 120 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.90426975 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.48751191 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.29551956 |
| 3 | MP0003191_abnormal_cellular_cholesterol | 3.10130140 |
| 4 | MP0009840_abnormal_foam_cell | 2.99730499 |
| 5 | MP0003172_abnormal_lysosome_physiology | 2.89544356 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.80279638 |
| 7 | MP0005365_abnormal_bile_salt | 2.70849358 |
| 8 | MP0000685_abnormal_immune_system | 2.54409591 |
| 9 | MP0003436_decreased_susceptibility_to | 2.51427169 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 2.49184584 |
| 11 | MP0005464_abnormal_platelet_physiology | 2.44392162 |
| 12 | MP0005360_urolithiasis | 2.31038946 |
| 13 | * MP0002419_abnormal_innate_immunity | 2.28042380 |
| 14 | MP0003303_peritoneal_inflammation | 2.19224421 |
| 15 | MP0008260_abnormal_autophagy | 2.17912887 |
| 16 | MP0001790_abnormal_immune_system | 2.15382315 |
| 17 | MP0005387_immune_system_phenotype | 2.15382315 |
| 18 | MP0006082_CNS_inflammation | 2.07964645 |
| 19 | MP0001800_abnormal_humoral_immune | 2.07681848 |
| 20 | MP0005085_abnormal_gallbladder_physiolo | 2.07208986 |
| 21 | MP0005025_abnormal_response_to | 2.05423760 |
| 22 | MP0001873_stomach_inflammation | 2.04759679 |
| 23 | MP0009785_altered_susceptibility_to | 2.03950788 |
| 24 | * MP0002452_abnormal_antigen_presenting | 2.00056356 |
| 25 | MP0005671_abnormal_response_to | 1.97351025 |
| 26 | MP0005000_abnormal_immune_tolerance | 1.88558705 |
| 27 | * MP0002723_abnormal_immune_serum | 1.84815531 |
| 28 | MP0003183_abnormal_peptide_metabolism | 1.82333317 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.79684433 |
| 30 | * MP0002420_abnormal_adaptive_immunity | 1.78908215 |
| 31 | * MP0001819_abnormal_immune_cell | 1.77844144 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.73130348 |
| 33 | MP0005083_abnormal_biliary_tract | 1.71258362 |
| 34 | MP0004510_myositis | 1.70173810 |
| 35 | MP0008875_abnormal_xenobiotic_pharmacok | 1.69598450 |
| 36 | MP0002254_reproductive_system_inflammat | 1.68705418 |
| 37 | MP0003075_altered_response_to | 1.62583846 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.62184458 |
| 39 | MP0003252_abnormal_bile_duct | 1.58598344 |
| 40 | MP0008469_abnormal_protein_level | 1.58566553 |
| 41 | MP0001853_heart_inflammation | 1.58190333 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.55930618 |
| 43 | MP0010329_abnormal_lipoprotein_level | 1.55556006 |
| 44 | MP0002398_abnormal_bone_marrow | 1.54511712 |
| 45 | MP0000716_abnormal_immune_system | 1.53550045 |
| 46 | MP0005451_abnormal_body_composition | 1.52670650 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.49264688 |
| 48 | MP0000465_gastrointestinal_hemorrhage | 1.44992551 |
| 49 | MP0002405_respiratory_system_inflammati | 1.44666040 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.40837472 |
| 51 | MP0003724_increased_susceptibility_to | 1.39804374 |
| 52 | MP0002166_altered_tumor_susceptibility | 1.39578871 |
| 53 | MP0002429_abnormal_blood_cell | 1.39478227 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.38294371 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.38294371 |
| 56 | MP0002722_abnormal_immune_system | 1.36096957 |
| 57 | MP0009764_decreased_sensitivity_to | 1.34779649 |
| 58 | MP0005220_abnormal_exocrine_pancreas | 1.32353836 |
| 59 | MP0003828_pulmonary_edema | 1.30316643 |
| 60 | MP0000609_abnormal_liver_physiology | 1.29381839 |
| 61 | MP0009278_abnormal_bone_marrow | 1.26750837 |
| 62 | MP0009333_abnormal_splenocyte_physiolog | 1.25846984 |
| 63 | MP0004808_abnormal_hematopoietic_stem | 1.25157978 |
| 64 | MP0005319_abnormal_enzyme/_coenzyme | 1.23408403 |
| 65 | MP0001666_abnormal_nutrient_absorption | 1.19444257 |
| 66 | MP0003186_abnormal_redox_activity | 1.18761805 |
| 67 | MP0003763_abnormal_thymus_physiology | 1.17764114 |
| 68 | MP0010155_abnormal_intestine_physiology | 1.16326027 |
| 69 | MP0003656_abnormal_erythrocyte_physiolo | 1.16157673 |
| 70 | MP0002933_joint_inflammation | 1.14364904 |
| 71 | MP0005174_abnormal_tail_pigmentation | 1.12804312 |
| 72 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.10972075 |
| 73 | MP0005332_abnormal_amino_acid | 1.10227852 |
| 74 | MP0002138_abnormal_hepatobiliary_system | 1.08922146 |
| 75 | MP0004947_skin_inflammation | 1.08853114 |
| 76 | MP0005310_abnormal_salivary_gland | 1.07971885 |
| 77 | MP0009643_abnormal_urine_homeostasis | 1.05067283 |
| 78 | MP0000598_abnormal_liver_morphology | 1.04319771 |
| 79 | MP0003806_abnormal_nucleotide_metabolis | 1.04304513 |
| 80 | MP0002118_abnormal_lipid_homeostasis | 1.03757294 |
| 81 | MP0004883_abnormal_blood_vessel | 0.99611741 |
| 82 | MP0000490_abnormal_crypts_of | 0.97903396 |
| 83 | MP0009763_increased_sensitivity_to | 0.97712698 |
| 84 | MP0004381_abnormal_hair_follicle | 0.97008167 |
| 85 | MP0001764_abnormal_homeostasis | 0.95980928 |
| 86 | MP0000604_amyloidosis | 0.90965178 |
| 87 | MP0005390_skeleton_phenotype | 0.90781190 |
| 88 | MP0000858_altered_metastatic_potential | 0.89889937 |
| 89 | MP0003448_altered_tumor_morphology | 0.89474713 |
| 90 | MP0005166_decreased_susceptibility_to | 0.88223764 |
| 91 | MP0003638_abnormal_response/metabolism_ | 0.87336400 |
| 92 | MP0000343_altered_response_to | 0.87248688 |
| 93 | MP0001663_abnormal_digestive_system | 0.87235461 |
| 94 | MP0002006_tumorigenesis | 0.87212417 |
| 95 | MP0005075_abnormal_melanosome_morpholog | 0.86094748 |
| 96 | MP0005670_abnormal_white_adipose | 0.86040632 |
| 97 | MP0004019_abnormal_vitamin_homeostasis | 0.85075799 |
| 98 | MP0002132_abnormal_respiratory_system | 0.84840575 |
| 99 | MP0001851_eye_inflammation | 0.84781875 |
| 100 | MP0002998_abnormal_bone_remodeling | 0.83770949 |
| 101 | MP0008438_abnormal_cutaneous_collagen | 0.82994720 |
| 102 | MP0003283_abnormal_digestive_organ | 0.82537074 |
| 103 | MP0002928_abnormal_bile_duct | 0.82187757 |
| 104 | MP0002019_abnormal_tumor_incidence | 0.82007149 |
| 105 | MP0008007_abnormal_cellular_replicative | 0.81727234 |
| 106 | MP0003866_abnormal_defecation | 0.81610646 |
| 107 | MP0005164_abnormal_response_to | 0.81397503 |
| 108 | MP0008004_abnormal_stomach_pH | 0.78563715 |
| 109 | MP0009642_abnormal_blood_homeostasis | 0.77193955 |
| 110 | MP0003690_abnormal_glial_cell | 0.77112986 |
| 111 | MP0006054_spinal_hemorrhage | 0.76935813 |
| 112 | MP0000371_diluted_coat_color | 0.74805218 |
| 113 | MP0000015_abnormal_ear_pigmentation | 0.69941712 |
| 114 | MP0002277_abnormal_respiratory_mucosa | 0.69480744 |
| 115 | MP0003795_abnormal_bone_structure | 0.68348891 |
| 116 | MP0000249_abnormal_blood_vessel | 0.63483758 |
| 117 | MP0005165_increased_susceptibility_to | 0.61052063 |
| 118 | MP0009765_abnormal_xenobiotic_induced | 0.60252057 |
| 119 | MP0008874_decreased_physiological_sensi | 0.57568489 |
| 120 | MP0000313_abnormal_cell_death | 0.52679305 |
| 121 | MP0006036_abnormal_mitochondrial_physio | 0.49704608 |
| 122 | MP0005381_digestive/alimentary_phenotyp | 0.49034748 |
| 123 | MP0003453_abnormal_keratinocyte_physiol | 0.48419637 |
| 124 | MP0008873_increased_physiological_sensi | 0.47531049 |
| 125 | MP0005084_abnormal_gallbladder_morpholo | 0.47520271 |
| 126 | MP0002877_abnormal_melanocyte_morpholog | 0.47243582 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dysostosis multiplex (HP:0000943) | 4.43515270 |
| 2 | Chronic obstructive pulmonary disease (HP:0006510) | 4.40133997 |
| 3 | Stomatitis (HP:0010280) | 4.19148353 |
| 4 | Mucopolysacchariduria (HP:0008155) | 4.12996337 |
| 5 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.12996337 |
| 6 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.95351918 |
| 7 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.95351918 |
| 8 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.95351918 |
| 9 | Orchitis (HP:0100796) | 3.94322838 |
| 10 | Recurrent abscess formation (HP:0002722) | 3.90848528 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 3.82099644 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 3.75768218 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 3.74186122 |
| 14 | Thrombocytosis (HP:0001894) | 3.58682109 |
| 15 | Agammaglobulinemia (HP:0004432) | 3.54822021 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.51745081 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.50248044 |
| 18 | Optic neuritis (HP:0100653) | 3.50248044 |
| 19 | Eczematoid dermatitis (HP:0000976) | 3.47197158 |
| 20 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.42812816 |
| 21 | Increased IgE level (HP:0003212) | 3.35839332 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.35247899 |
| 23 | Increased cerebral lipofuscin (HP:0011813) | 3.23398618 |
| 24 | Urticaria (HP:0001025) | 3.21431361 |
| 25 | Encephalitis (HP:0002383) | 3.19441023 |
| 26 | Chronic otitis media (HP:0000389) | 3.07619783 |
| 27 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.00105238 |
| 28 | Glomerulonephritis (HP:0000099) | 2.98867051 |
| 29 | Gastrointestinal infarctions (HP:0005244) | 2.95778058 |
| 30 | Complement deficiency (HP:0004431) | 2.90358169 |
| 31 | Chest pain (HP:0100749) | 2.88954403 |
| 32 | Hepatosplenomegaly (HP:0001433) | 2.84701867 |
| 33 | Recurrent skin infections (HP:0001581) | 2.84019006 |
| 34 | IgM deficiency (HP:0002850) | 2.81031215 |
| 35 | Abnormality of complement system (HP:0005339) | 2.79194964 |
| 36 | Reduced antithrombin III activity (HP:0001976) | 2.75967747 |
| 37 | Myositis (HP:0100614) | 2.75539392 |
| 38 | Osteomyelitis (HP:0002754) | 2.74395933 |
| 39 | Deep venous thrombosis (HP:0002625) | 2.69845467 |
| 40 | Pulmonary infiltrates (HP:0002113) | 2.69045047 |
| 41 | Interstitial pulmonary disease (HP:0006530) | 2.68209614 |
| 42 | Abnormality of macrophages (HP:0004311) | 2.67966463 |
| 43 | Granulocytopenia (HP:0001913) | 2.67484820 |
| 44 | Increased IgM level (HP:0003496) | 2.65747842 |
| 45 | Joint hemorrhage (HP:0005261) | 2.65554429 |
| 46 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.58712961 |
| 47 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.58712961 |
| 48 | Abnormality of glycolipid metabolism (HP:0010969) | 2.58712961 |
| 49 | Impaired platelet aggregation (HP:0003540) | 2.58124185 |
| 50 | Abnormal platelet function (HP:0011869) | 2.58124185 |
| 51 | Increased serum ferritin (HP:0003281) | 2.56936528 |
| 52 | Thoracic kyphosis (HP:0002942) | 2.54277037 |
| 53 | Episodic fever (HP:0001954) | 2.51421088 |
| 54 | Sepsis (HP:0100806) | 2.50932751 |
| 55 | Recurrent fungal infections (HP:0002841) | 2.50857316 |
| 56 | Petechiae (HP:0000967) | 2.47945894 |
| 57 | Vertebral compression fractures (HP:0002953) | 2.47027191 |
| 58 | Hemoptysis (HP:0002105) | 2.45700632 |
| 59 | Epistaxis (HP:0000421) | 2.44331674 |
| 60 | Leukocytosis (HP:0001974) | 2.44276267 |
| 61 | Hypergammaglobulinemia (HP:0010702) | 2.44101306 |
| 62 | Prolonged partial thromboplastin time (HP:0003645) | 2.42508453 |
| 63 | Progressive neurologic deterioration (HP:0002344) | 2.41669823 |
| 64 | Keratoconjunctivitis sicca (HP:0001097) | 2.41656519 |
| 65 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.40417340 |
| 66 | Gingival bleeding (HP:0000225) | 2.40223329 |
| 67 | Prolonged bleeding time (HP:0003010) | 2.40103659 |
| 68 | Gastrointestinal inflammation (HP:0004386) | 2.38256251 |
| 69 | Colitis (HP:0002583) | 2.37685215 |
| 70 | Abnormality of the intrinsic pathway (HP:0010989) | 2.37245113 |
| 71 | Lymphopenia (HP:0001888) | 2.36610865 |
| 72 | Periodontitis (HP:0000704) | 2.35651061 |
| 73 | Xanthomatosis (HP:0000991) | 2.35111833 |
| 74 | Intrahepatic cholestasis (HP:0001406) | 2.34198248 |
| 75 | Abnormality of T cells (HP:0002843) | 2.32647178 |
| 76 | Autoimmune thrombocytopenia (HP:0001973) | 2.32074834 |
| 77 | Loss of speech (HP:0002371) | 2.31746690 |
| 78 | Late onset (HP:0003584) | 2.31241434 |
| 79 | Cellulitis (HP:0100658) | 2.30564532 |
| 80 | Joint stiffness (HP:0001387) | 2.30123262 |
| 81 | Arterial thrombosis (HP:0004420) | 2.29828583 |
| 82 | Recurrent viral infections (HP:0004429) | 2.29695913 |
| 83 | Abnormality of the common coagulation pathway (HP:0010990) | 2.29084193 |
| 84 | Inflammation of the large intestine (HP:0002037) | 2.27734553 |
| 85 | Recurrent pneumonia (HP:0006532) | 2.27298183 |
| 86 | Skin rash (HP:0000988) | 2.24092914 |
| 87 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.24009046 |
| 88 | Abnormality of iron homeostasis (HP:0011031) | 2.23858120 |
| 89 | Pulmonary embolism (HP:0002204) | 2.23100073 |
| 90 | Abnormality of the thoracic spine (HP:0100711) | 2.23012073 |
| 91 | T lymphocytopenia (HP:0005403) | 2.21157484 |
| 92 | Abnormality of the prostate (HP:0008775) | 2.20665706 |
| 93 | Hypochromic anemia (HP:0001931) | 2.20566755 |
| 94 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.19478795 |
| 95 | Mediastinal lymphadenopathy (HP:0100721) | 2.19340931 |
| 96 | Hypertensive crisis (HP:0100735) | 2.19093402 |
| 97 | Large eyes (HP:0001090) | 2.18218158 |
| 98 | Recurrent lower respiratory tract infections (HP:0002783) | 2.16957048 |
| 99 | Keratoconjunctivitis (HP:0001096) | 2.16245369 |
| 100 | Purpura (HP:0000979) | 2.15294760 |
| 101 | Skin ulcer (HP:0200042) | 2.13909532 |
| 102 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.13522014 |
| 103 | Recurrent cutaneous fungal infections (HP:0011370) | 2.13522014 |
| 104 | Abnormality of T cell physiology (HP:0011840) | 2.13473558 |
| 105 | Hypochromic microcytic anemia (HP:0004840) | 2.12008098 |
| 106 | Type I transferrin isoform profile (HP:0003642) | 2.10750797 |
| 107 | Meningitis (HP:0001287) | 2.10038962 |
| 108 | Abnormality of the pleura (HP:0002103) | 2.09700656 |
| 109 | Beaking of vertebral bodies (HP:0004568) | 2.08737711 |
| 110 | Hypoglycemic coma (HP:0001325) | 2.08696239 |
| 111 | Anorexia (HP:0002039) | 2.07704332 |
| 112 | Abnormality of T cell number (HP:0011839) | 2.06903164 |
| 113 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.06779911 |
| 114 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.06779911 |
| 115 | Abnormal protein glycosylation (HP:0012346) | 2.06779911 |
| 116 | Abnormal glycosylation (HP:0012345) | 2.06779911 |
| 117 | Recurrent bronchitis (HP:0002837) | 2.00342642 |
| 118 | Autoimmune hemolytic anemia (HP:0001890) | 1.99770166 |
| 119 | Eosinophilia (HP:0001880) | 1.99572161 |
| 120 | Papilloma (HP:0012740) | 1.99551215 |
| 121 | Verrucae (HP:0200043) | 1.99551215 |
| 122 | Vasculitis (HP:0002633) | 1.98160788 |
| 123 | Glomerulopathy (HP:0100820) | 1.97501651 |
| 124 | Pathologic fracture (HP:0002756) | 1.97427330 |
| 125 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.96903258 |
| 126 | Gangrene (HP:0100758) | 1.96333478 |
| 127 | Tetraparesis (HP:0002273) | 1.96092225 |
| 128 | Abnormality of the lumbar spine (HP:0100712) | 1.95987028 |
| 129 | Abnormality of B cell number (HP:0010975) | 1.94673087 |
| 130 | Gastrointestinal stroma tumor (HP:0100723) | 1.94246496 |
| 131 | Ketosis (HP:0001946) | 1.93096006 |
| 132 | Mitral stenosis (HP:0001718) | 1.92981729 |
| 133 | Axonal loss (HP:0003447) | 1.92646675 |
| 134 | Spontaneous hematomas (HP:0007420) | 1.92074433 |
| 135 | Panhypogammaglobulinemia (HP:0003139) | 1.90258525 |
| 136 | Amyloidosis (HP:0011034) | 1.90080471 |
| 137 | Cardiomegaly (HP:0001640) | 1.89937717 |
| 138 | Menorrhagia (HP:0000132) | 1.89182327 |
| 139 | Abnormality of the nasal mucosa (HP:0000433) | 1.86550767 |
| 140 | Nephritis (HP:0000123) | 1.86443637 |
| 141 | Pustule (HP:0200039) | 1.85315577 |
| 142 | Generalized aminoaciduria (HP:0002909) | 1.84186830 |
| 143 | Poikiloderma (HP:0001029) | 1.82143608 |
| 144 | Gingivitis (HP:0000230) | 1.82121843 |
| 145 | Albinism (HP:0001022) | 1.81994305 |
| 146 | Polygenic inheritance (HP:0010982) | 1.81431090 |
| 147 | Emphysema (HP:0002097) | 1.79860013 |
| 148 | Myocardial infarction (HP:0001658) | 1.78016722 |
| 149 | Nasal polyposis (HP:0100582) | 1.77503971 |
| 150 | Obstructive lung disease (HP:0006536) | 1.77154728 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.94408343 |
| 2 | KIT | 3.67421732 |
| 3 | MAP4K1 | 3.47202411 |
| 4 | FLT3 | 2.83759470 |
| 5 | TRIB3 | 2.64978544 |
| 6 | MAP2K3 | 2.64746620 |
| 7 | CSF1R | 2.63938783 |
| 8 | BCKDK | 2.33377555 |
| 9 | TGFBR2 | 2.30694701 |
| 10 | TYK2 | 2.22694123 |
| 11 | SIK1 | 2.21461369 |
| 12 | PKN2 | 2.18605911 |
| 13 | PRPF4B | 2.17760518 |
| 14 | TAOK3 | 2.17349346 |
| 15 | TBK1 | 2.13247555 |
| 16 | BTK | 2.06583407 |
| 17 | IRAK4 | 1.99908154 |
| 18 | EEF2K | 1.75539812 |
| 19 | BLK | 1.66152283 |
| 20 | SCYL2 | 1.62396400 |
| 21 | SMG1 | 1.56294309 |
| 22 | TEC | 1.56206243 |
| 23 | TAOK1 | 1.49240513 |
| 24 | STK16 | 1.49231809 |
| 25 | ZAP70 | 1.47865376 |
| 26 | SYK | 1.47112180 |
| 27 | MAP3K3 | 1.40305260 |
| 28 | IRAK3 | 1.38547985 |
| 29 | JAK1 | 1.37962340 |
| 30 | FGR | 1.36987692 |
| 31 | SIK3 | 1.36588945 |
| 32 | MATK | 1.36208778 |
| 33 | FES | 1.33969606 |
| 34 | CAMKK2 | 1.28777189 |
| 35 | VRK2 | 1.26581290 |
| 36 | MAP3K13 | 1.26169428 |
| 37 | JAK3 | 1.23209564 |
| 38 | KDR | 1.20522989 |
| 39 | RPS6KA4 | 1.20380800 |
| 40 | CSK | 1.18914501 |
| 41 | LYN | 1.13549978 |
| 42 | SIK2 | 1.12823566 |
| 43 | PIM2 | 1.11341429 |
| 44 | FGFR4 | 1.09216886 |
| 45 | GRK6 | 1.09099009 |
| 46 | BMPR2 | 1.08761963 |
| 47 | ADRBK2 | 1.08518071 |
| 48 | MAP3K10 | 1.05796064 |
| 49 | TESK2 | 1.04261315 |
| 50 | HCK | 1.02508853 |
| 51 | PAK4 | 1.00820860 |
| 52 | EIF2AK3 | 1.00126906 |
| 53 | TESK1 | 0.98285848 |
| 54 | STK10 | 0.95908076 |
| 55 | LRRK2 | 0.95661372 |
| 56 | IKBKB | 0.93685098 |
| 57 | MAP3K11 | 0.91493685 |
| 58 | IKBKE | 0.90972695 |
| 59 | ARAF | 0.89863332 |
| 60 | ITK | 0.84043928 |
| 61 | BUB1 | 0.82798671 |
| 62 | JAK2 | 0.79969110 |
| 63 | CAMKK1 | 0.79272864 |
| 64 | EPHB1 | 0.76842285 |
| 65 | PTK6 | 0.74420100 |
| 66 | MAPK15 | 0.73984866 |
| 67 | HIPK2 | 0.73944352 |
| 68 | CDK19 | 0.73743089 |
| 69 | TAOK2 | 0.73730659 |
| 70 | NEK9 | 0.71708877 |
| 71 | RIPK4 | 0.71389318 |
| 72 | LCK | 0.69514398 |
| 73 | IRAK2 | 0.69113395 |
| 74 | CAMK1D | 0.67835049 |
| 75 | MAP2K6 | 0.67731922 |
| 76 | PDK1 | 0.66890163 |
| 77 | CLK1 | 0.64587084 |
| 78 | NME2 | 0.63367067 |
| 79 | PASK | 0.62054789 |
| 80 | MARK2 | 0.60979956 |
| 81 | TNK2 | 0.59978817 |
| 82 | PDPK1 | 0.59577448 |
| 83 | YES1 | 0.59239578 |
| 84 | PRKD2 | 0.54241016 |
| 85 | MAPK12 | 0.53928323 |
| 86 | MOS | 0.52523667 |
| 87 | MAP3K14 | 0.51027739 |
| 88 | MAPK11 | 0.50320847 |
| 89 | PIK3CG | 0.49984909 |
| 90 | PRKCH | 0.49308117 |
| 91 | BMX | 0.49151668 |
| 92 | DAPK1 | 0.48458476 |
| 93 | FYN | 0.48000772 |
| 94 | PRKCQ | 0.47520716 |
| 95 | MAPKAPK3 | 0.47218289 |
| 96 | GRK7 | 0.46950721 |
| 97 | MAP3K5 | 0.46047048 |
| 98 | MAPKAPK2 | 0.45838480 |
| 99 | KSR2 | 0.45307237 |
| 100 | PRKG2 | 0.44946144 |
| 101 | PIM1 | 0.44802605 |
| 102 | TXK | 0.43994846 |
| 103 | ABL2 | 0.41902682 |
| 104 | PRKCD | 0.41334827 |
| 105 | TIE1 | 0.40821216 |
| 106 | MAP3K8 | 0.40795442 |
| 107 | DYRK1B | 0.40756481 |
| 108 | CDK6 | 0.40272068 |
| 109 | MAPK7 | 0.40262113 |
| 110 | INSRR | 0.40200729 |
| 111 | MAPK4 | 0.39439587 |
| 112 | RPS6KC1 | 0.38458486 |
| 113 | RPS6KL1 | 0.38458486 |
| 114 | MARK3 | 0.37143575 |
| 115 | CAMK4 | 0.37043778 |
| 116 | VRK1 | 0.35692350 |
| 117 | MAP3K6 | 0.35214387 |
| 118 | CDC42BPA | 0.34972276 |
| 119 | MAP3K1 | 0.34680281 |
| 120 | RAF1 | 0.33920675 |
| 121 | EPHA3 | 0.33222557 |
| 122 | ATR | 0.32693047 |
| 123 | MAP3K7 | 0.32415192 |
| 124 | IRAK1 | 0.32013875 |
| 125 | EGFR | 0.31705607 |
| 126 | MAPKAPK5 | 0.31639573 |
| 127 | PAK1 | 0.31056431 |
| 128 | NEK2 | 0.31000720 |
| 129 | CHUK | 0.30522926 |
| 130 | CDK4 | 0.29939222 |
| 131 | PAK2 | 0.29791984 |
| 132 | TGFBR1 | 0.28760182 |
| 133 | CCNB1 | 0.28708106 |
| 134 | MAP2K2 | 0.26747425 |
| 135 | RPS6KA6 | 0.24841969 |
| 136 | PRKD1 | 0.23933772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.33508437 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.12237099 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.96346187 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.95162452 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.91024744 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.87794677 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.69720965 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.56992952 |
| 9 | Lysosome_Homo sapiens_hsa04142 | 2.33902331 |
| 10 | Sulfur relay system_Homo sapiens_hsa04122 | 2.30699564 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.26188131 |
| 12 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.15990792 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.05441280 |
| 14 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.01795420 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.98681880 |
| 16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.98098016 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.95780914 |
| 18 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.93450156 |
| 19 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.91156537 |
| 20 | DNA replication_Homo sapiens_hsa03030 | 1.86319121 |
| 21 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.84833079 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.80635854 |
| 23 | Protein export_Homo sapiens_hsa03060 | 1.71750645 |
| 24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.69480814 |
| 25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.66539056 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.64366720 |
| 27 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.62063377 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.58776790 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.55502214 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.53094377 |
| 31 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.50537389 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.50068984 |
| 33 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.40603654 |
| 34 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.37659207 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.37453026 |
| 36 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.28978506 |
| 37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.27152270 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.26020199 |
| 39 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.25788626 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.24088041 |
| 41 | Legionellosis_Homo sapiens_hsa05134 | 1.23379327 |
| 42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.23199207 |
| 43 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.21312524 |
| 44 | Galactose metabolism_Homo sapiens_hsa00052 | 1.21266908 |
| 45 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.21124660 |
| 46 | Peroxisome_Homo sapiens_hsa04146 | 1.19971772 |
| 47 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.19116415 |
| 48 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.18846109 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.18113595 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 1.16683444 |
| 51 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.11899447 |
| 52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09694299 |
| 53 | Base excision repair_Homo sapiens_hsa03410 | 1.09665890 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 1.07792877 |
| 55 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.07155612 |
| 56 | Histidine metabolism_Homo sapiens_hsa00340 | 1.04550435 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 1.03973323 |
| 58 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.03970500 |
| 59 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.02770906 |
| 60 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.02632230 |
| 61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.01858733 |
| 62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.01395954 |
| 63 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.01007090 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00057810 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.98437578 |
| 66 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.97580909 |
| 67 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.96066697 |
| 68 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.92631732 |
| 69 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.91248631 |
| 70 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.91220255 |
| 71 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.90950072 |
| 72 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.87718984 |
| 73 | Tuberculosis_Homo sapiens_hsa05152 | 0.87028665 |
| 74 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.85809222 |
| 75 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.85055144 |
| 76 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.82793509 |
| 77 | Measles_Homo sapiens_hsa05162 | 0.82734271 |
| 78 | Mismatch repair_Homo sapiens_hsa03430 | 0.82634416 |
| 79 | Hepatitis C_Homo sapiens_hsa05160 | 0.82558018 |
| 80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.81709592 |
| 81 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81596477 |
| 82 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80721026 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79275341 |
| 84 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.77507256 |
| 85 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.76806896 |
| 86 | HTLV-I infection_Homo sapiens_hsa05166 | 0.73598544 |
| 87 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73229723 |
| 88 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.72845619 |
| 89 | Carbon metabolism_Homo sapiens_hsa01200 | 0.69862556 |
| 90 | Malaria_Homo sapiens_hsa05144 | 0.68942425 |
| 91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68146638 |
| 92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.68115899 |
| 93 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.67402515 |
| 94 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66934039 |
| 95 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.66895231 |
| 96 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.66574293 |
| 97 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.66541479 |
| 98 | Endocytosis_Homo sapiens_hsa04144 | 0.66522992 |
| 99 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.65633931 |
| 100 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.65239069 |
| 101 | Ribosome_Homo sapiens_hsa03010 | 0.65232004 |
| 102 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64067671 |
| 103 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.63734983 |
| 104 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63149940 |
| 105 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62332870 |
| 106 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.62314627 |
| 107 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.61653978 |
| 108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61382973 |
| 109 | Apoptosis_Homo sapiens_hsa04210 | 0.60474711 |
| 110 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.59986374 |
| 111 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59104051 |
| 112 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.57376059 |
| 113 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57024593 |
| 114 | Lysine degradation_Homo sapiens_hsa00310 | 0.56942672 |
| 115 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.54812083 |
| 116 | Influenza A_Homo sapiens_hsa05164 | 0.54366504 |
| 117 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.53844253 |
| 118 | Shigellosis_Homo sapiens_hsa05131 | 0.53802165 |
| 119 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53677972 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53390841 |
| 121 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.53112409 |
| 122 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.51745282 |
| 123 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.51632037 |
| 124 | Phagosome_Homo sapiens_hsa04145 | 0.50781930 |
| 125 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50636987 |
| 126 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50262984 |
| 127 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.49838019 |
| 128 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.48178181 |
| 129 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.47842557 |
| 130 | Prion diseases_Homo sapiens_hsa05020 | 0.45856207 |
| 131 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.44763228 |
| 132 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44360029 |
| 133 | Hepatitis B_Homo sapiens_hsa05161 | 0.44096941 |
| 134 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43845031 |
| 135 | Bladder cancer_Homo sapiens_hsa05219 | 0.43209792 |
| 136 | Homologous recombination_Homo sapiens_hsa03440 | 0.41175753 |
| 137 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.39563872 |
| 138 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39467221 |
| 139 | Amoebiasis_Homo sapiens_hsa05146 | 0.38555342 |
| 140 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32470150 |
| 141 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.31646513 |
| 142 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29500145 |
| 143 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29068752 |
| 144 | Proteasome_Homo sapiens_hsa03050 | 0.29044316 |
| 145 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.28760475 |
| 146 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.28729675 |
| 147 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.25307140 |
| 148 | Colorectal cancer_Homo sapiens_hsa05210 | 0.25155429 |
| 149 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.24087915 |
| 150 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23750955 |
| 151 | Endometrial cancer_Homo sapiens_hsa05213 | 0.18029792 |

